RecruitingNot ApplicableNCT05599425

Health Behavior Change in Midlife Adults at Risk for Alzheimer's Disease

Development of a Personalized Intervention to Motivate Health Behavior Change in Midlife Adults at Risk for Alzheimer's Disease


Sponsor

Rhode Island Hospital

Enrollment

40 participants

Start Date

Mar 1, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Modifying health behaviors like physical activity level, diet, stress, and mental activity level can lower risk for Alzheimer's disease, but many middle-aged and older adults find it difficult to sustain health behavior changes over the long term. This project will develop a new intervention that educates people about Alzheimer's disease risk factors and helps them understand how their personal health beliefs may prevent them from making long-lasting lifestyle changes. The goal is to help people sustain health behavior changes to prevent or delay the onset of Alzheimer's disease and related dementias.


Eligibility

Min Age: 45 YearsMax Age: 69 Years

Inclusion Criteria4

  • age 45-69 years
  • normal cognition (Minnesota Cognitive Acuity Scale \> 52)
  • English language fluency
  • at least two of the following: i) BMI \> 24.9; ii) systolic blood pressure \> 125 mmHg; iii) LDL cholesterol \> 115 mg/dL; iv) HbA1C \> 6.0%; v) at least one APOE ε4 allele; vi) first-degree relative with AD.

Exclusion Criteria4

  • history of serious mental illness (i.e., schizophrenia, bipolar disorder)
  • history of neurologic or neurodevelopmental disorder
  • current alcohol or drug use disorder based on self-report
  • current enrollment in an AD prevention clinical trial.

Interventions

BEHAVIORALEnhanced Healthy Living Education

24-session healthy living education program, with enhanced content about health beliefs and mechanisms of behavior change

BEHAVIORALBasic Healthy Living Education

24-session healthy living education program


Locations(1)

Rhode Island Hospital

Providence, Rhode Island, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05599425


Related Trials